General Information of Drug (ID: DMT9FNB)

Drug Name
PF-06372865
Indication
Disease Entry ICD 11 Status REF
Chronic pain MG30 Phase 2 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H21FN4O3S
Canonical SMILES
CCN1C=NC2=C1N=NC=C2C3=CC(=C(C=C3)F)C4=C(C=C(C=C4)S(=O)(=O)CC)OC
InChI
InChI=1S/C22H21FN4O3S/c1-4-27-13-24-21-18(12-25-26-22(21)27)14-6-9-19(23)17(10-14)16-8-7-15(11-20(16)30-3)31(28,29)5-2/h6-13H,4-5H2,1-3H3
InChIKey
PTTQXDBPTFOCMT-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
76287260
ChEBI ID
CHEMBL3647536
CAS Number
1614245-70-3
TTD ID
D06TQR
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT02262754) PF-06372865 In Subjects With Chronic Low Back Pain. U.S. National Institutes of Health.